These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7608316)

  • 1. Pharmacokinetics and presystemic gut metabolism of methyldopa in healthy human subjects.
    Skerjanec A; Campbell NR; Robertson S; Tam YK
    J Clin Pharmacol; 1995 Mar; 35(3):275-80. PubMed ID: 7608316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of methyldopa.
    Myhre E; Rugstad HE; Hansen T
    Clin Pharmacokinet; 1982; 7(3):221-33. PubMed ID: 7047042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methyldopa in man.
    Kwan KC; Foltz EL; Breault GO; Baer JE; Totaro JA
    J Pharmacol Exp Ther; 1976 Aug; 198(2):264-77. PubMed ID: 781212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methyldopa. Plasma levels following single intravenous, oral and multiple oral dosage in normotensive and hypertensive subjects.
    Barnett AJ; Bobik A; Carson V; Korman JS; McLean AJ
    Clin Exp Pharmacol Physiol; 1977; 4(4):331-9. PubMed ID: 908178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyldopa kinetics before and after ingestion of methyldopa for eight weeks.
    Campbell NR; Skerjanec A; Tam Y; Robertson S; Burgess E
    Eur J Clin Pharmacol; 1995; 48(5):397-400. PubMed ID: 8641329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in methyldopa absorption and renal excretion after multiple doses.
    Campbell NR; Patrick W
    J Clin Pharmacol; 1992 May; 32(5):450-4. PubMed ID: 1587963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects.
    Harrell AW; Wilson R; Man YL; Riddell K; Jarvis E; Young G; Chambers R; Crossman L; Georgiou A; Pereira A; Kenworthy D; Beaumont C; Marotti M; Wilkes D; Hessel EM; Fahy WA
    Drug Metab Dispos; 2019 Dec; 47(12):1457-1468. PubMed ID: 31649125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo.
    Chikhale PJ; Borchardt RT
    Drug Metab Dispos; 1994; 22(4):592-600. PubMed ID: 7956735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of digoxin and main metabolites/derivatives in healthy humans.
    Hinderling PH; Hartmann D
    Ther Drug Monit; 1991 Sep; 13(5):381-401. PubMed ID: 1957331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single- and multiple-dose mibefradil pharmacokinetics in normal and hypertensive subjects.
    Welker HA
    J Pharm Pharmacol; 1998 Sep; 50(9):983-7. PubMed ID: 9811158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers.
    Crevoisier C; Monreal A; Metzger B; Nilsen T
    Eur Neurol; 2003; 49(1):39-44. PubMed ID: 12464717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.
    Hassan-Alin M; Andersson T; Bredberg E; Röhss K
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):665-70. PubMed ID: 11214773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers.
    Kaiser G; Ackermann R; Dieterle W; Reimann IW; Bieck PR
    Biopharm Drug Dispos; 1992 Mar; 13(2):83-93. PubMed ID: 1550911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man.
    Taylor G; Houston JB; Shaffer J; Mawer G
    Br J Clin Pharmacol; 1983 Mar; 15(3):287-93. PubMed ID: 6849764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.